Similar Items: Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
- Repurpose an FDA‐Approved Antibody Using DARPin‐Scaffolded Bridge Protein
- Development of human monoclonal antibodies against TARM1 by yeast display
- The use of monoclonal antibody for the immunodiagnosis of Fasciola gigantica infection in cattle
- Current GMP standards for the large‐scale production of monoclonal antibodies
- Development of novel monoclonal antibodies for detection of pan-Lassa virus
- Preparation and application of Taq DNA polymerase monoclonal antibody guided by structural domain analysis